相似文献
1
Tirandamycins from Streptomyces sp. 17944 inhibiting the parasite Brugia malayi asparagine tRNA synthetase.
Org Lett. 2011 Apr 15;13(8):2034-7. doi: 10.1021/ol200420u. Epub 2011 Mar 15.
2
New WS9326A congeners from Streptomyces sp. 9078 inhibiting Brugia malayi asparaginyl-tRNA synthetase.
Org Lett. 2012 Sep 21;14(18):4946-9. doi: 10.1021/ol302298k. Epub 2012 Sep 12.
3
Adipostatins A-D from Streptomyces sp. 4875 inhibiting Brugia malayi asparaginyl-tRNA synthetase and killing adult Brugia malayi parasites.
J Antibiot (Tokyo). 2015 Aug;68(8):540-2. doi: 10.1038/ja.2015.22. Epub 2015 Mar 4.
4
Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase.
J Mol Model. 2014 Jun;20(6):2266. doi: 10.1007/s00894-014-2266-9. Epub 2014 May 20.
5
Discovering new classes of Brugia malayi asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational change.
J Comput Aided Mol Des. 2006 Mar;20(3):159-78. doi: 10.1007/s10822-006-9043-5. Epub 2006 Apr 28.
6
Expression, localization and alternative function of cytoplasmic asparaginyl-tRNA synthetase in Brugia malayi.
Mol Biochem Parasitol. 2003 Jun;129(1):33-9. doi: 10.1016/s0166-6851(03)00080-x.
7
An immunodominant antigen of Brugia malayi is an asparaginyl-tRNA synthetase.
FEBS Lett. 1995 Oct 23;374(1):122-4. doi: 10.1016/0014-5793(95)01092-s.
8
A hybrid structural model of the complete Brugia malayi cytoplasmic asparaginyl-tRNA synthetase.
J Mol Biol. 2011 Jan 28;405(4):1056-69. doi: 10.1016/j.jmb.2010.11.049. Epub 2010 Dec 4.
9
Brugia malayi asparaginyl-transfer RNA synthetase induces chemotaxis of human leukocytes and activates G-protein-coupled receptors CXCR1 and CXCR2.
J Infect Dis. 2006 Apr 15;193(8):1164-71. doi: 10.1086/501369. Epub 2006 Mar 6.
10
Immune Response to Asparaginyl-tRNA Synthetase in Balb/c Mice and Human Clinical Samples of Lymphatic Filariasis.
Lymphat Res Biol. 2019 Aug;17(4):447-456. doi: 10.1089/lrb.2018.0003. Epub 2018 Dec 20.
引用本文的文献
1
Evaluation of tirandamycins with selective activity against Enterococci in the silkworm infection model.
J Antibiot (Tokyo). 2025 Mar;78(4):211-218. doi: 10.1038/s41429-024-00805-4. Epub 2025 Feb 14.
2
Broad anti-pathogen potential of DEAD box RNA helicase eIF4A-targeting rocaglates.
Sci Rep. 2023 Jun 8;13(1):9297. doi: 10.1038/s41598-023-35765-6.
3
New insights into the neuroprotective and beta-secretase1 inhibitor profiles of tirandamycin B isolated from a newly found Streptomyces composti sp. nov.
Sci Rep. 2023 Mar 24;13(1):4825. doi: 10.1038/s41598-023-32043-3.
4
Contemporary exploitation of natural products for arthropod-borne pathogen transmission-blocking interventions.
Parasit Vectors. 2022 Aug 24;15(1):298. doi: 10.1186/s13071-022-05367-8.
5
Engineering P450 TamI as an Iterative Biocatalyst for Selective Late-Stage C-H Functionalization and Epoxidation of Tirandamycin Antibiotics.
ACS Catal. 2021 Jul 2;11(13):8304-8316. doi: 10.1021/acscatal.1c01460. Epub 2021 Jun 22.
6
Natural Products from Actinomycetes Associated with Marine Organisms.
Mar Drugs. 2021 Nov 10;19(11):629. doi: 10.3390/md19110629.
7
Mining Indonesian Microbial Biodiversity for Novel Natural Compounds by a Combined Genome Mining and Molecular Networking Approach.
Mar Drugs. 2021 May 28;19(6):316. doi: 10.3390/md19060316.
8
Asparaginyl-tRNA Synthetase, a Novel Component of Hippo Signaling, Binds to Salvador and Enhances Yorkie-Mediated Tumorigenesis.
Front Cell Dev Biol. 2020 Feb 5;8:32. doi: 10.3389/fcell.2020.00032. eCollection 2020.
9
Leveraging a large microbial strain collection for natural product discovery.
J Biol Chem. 2019 Nov 8;294(45):16567-16576. doi: 10.1074/jbc.REV119.006514. Epub 2019 Sep 30.
10
sp. nov., a Novel Marine Sponge-Derived Actinobacterium With Antibacterial Potential Against .
Front Microbiol. 2019 Mar 13;10:482. doi: 10.3389/fmicb.2019.00482. eCollection 2019.
本文引用的文献
1
Capacity building in anthelmintic drug discovery.
Expert Opin Drug Discov. 2007 Oct;2(s1):S75-82. doi: 10.1517/17460441.2.S1.S75.
2
Ivermectin resistance and overview of the Consortium for Anthelmintic Resistance SNPs.
Expert Opin Drug Discov. 2007 Oct;2(s1):S41-52. doi: 10.1517/17460441.2.S1.S41.
3
Anthelmintic discovery and development in the animal health industry.
Expert Opin Drug Discov. 2007 Oct;2(s1):S25-33. doi: 10.1517/17460441.2.S1.S25.
4
Helminth drug initiative.
Expert Opin Drug Discov. 2007 Oct;2(s1):S1. doi: 10.1517/17460441.2.S1.S1.
5
A hybrid structural model of the complete Brugia malayi cytoplasmic asparaginyl-tRNA synthetase.
J Mol Biol. 2011 Jan 28;405(4):1056-69. doi: 10.1016/j.jmb.2010.11.049. Epub 2010 Dec 4.
6
Asparaginyl-tRNA synthetase pre-transfer editing assay.
Curr Drug Discov Technol. 2011 Mar;8(1):66-75. doi: 10.2174/157016311794519947.
7
Elimination of lymphatic filariasis: do we have the drugs to complete the job?
Curr Opin Infect Dis. 2010 Dec;23(6):617-20. doi: 10.1097/QCO.0b013e32833fdee5.
8
Identification of the tirandamycin biosynthetic gene cluster from Streptomyces sp. 307-9.
Chembiochem. 2010 Mar 1;11(4):564-72. doi: 10.1002/cbic.200900658.
9
Isolation and characterization of tirandamycins from a marine-derived Streptomyces sp.
J Nat Prod. 2009 Nov;72(11):2076-9. doi: 10.1021/np9005597.
10
Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis.
Curr Opin Infect Dis. 2008 Dec;21(6):673-81. doi: 10.1097/QCO.0b013e328315cde7.
Zotero 插件